US 11059814
Kinase inhibitors and methods for making and using
granted A61PA61P29/00
Quick answer
US patent 11059814 (Kinase inhibitors and methods for making and using) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P29/00